286 related articles for article (PubMed ID: 30843353)
1. Bio-adrenomedullin as a marker of congestion in patients with new-onset and worsening heart failure.
Ter Maaten JM; Kremer D; Demissei BG; Struck J; Bergmann A; Anker SD; Ng LL; Dickstein K; Metra M; Samani NJ; Romaine SPR; Cleland J; Girerd N; Lang CC; van Veldhuisen DJ; Voors AA
Eur J Heart Fail; 2019 Jun; 21(6):732-743. PubMed ID: 30843353
[TBL] [Abstract][Full Text] [Related]
2. Bioactive adrenomedullin as a marker of congestion and disease progression in patients with a systemic right ventricle.
Ansari Ramandi MM; Hendriks PM; Voors AA; van den Bosch AE; van Melle JP
Int J Cardiol; 2024 Aug; 408():132107. PubMed ID: 38685456
[TBL] [Abstract][Full Text] [Related]
3. Clinical value of pre-discharge bio-adrenomedullin as a marker of residual congestion and high risk of heart failure hospital readmission.
Pandhi P; Ter Maaten JM; Emmens JE; Struck J; Bergmann A; Cleland JG; Givertz MM; Metra M; O'Connor CM; Teerlink JR; Ponikowski P; Cotter G; Davison B; van Veldhuisen DJ; Voors AA
Eur J Heart Fail; 2020 Apr; 22(4):683-691. PubMed ID: 31797505
[TBL] [Abstract][Full Text] [Related]
4. Adrenomedullin in heart failure: pathophysiology and therapeutic application.
Voors AA; Kremer D; Geven C; Ter Maaten JM; Struck J; Bergmann A; Pickkers P; Metra M; Mebazaa A; Düngen HD; Butler J
Eur J Heart Fail; 2019 Feb; 21(2):163-171. PubMed ID: 30592365
[TBL] [Abstract][Full Text] [Related]
5. Bioactive adrenomedullin for assessment of venous congestion in heart failure.
Egerstedt A; Czuba T; Bronton K; Lejonberg C; Ruge T; Wessman T; Rådegran G; Schulte J; Hartmann O; Melander O; Smith JG
ESC Heart Fail; 2022 Oct; 9(5):3543-3555. PubMed ID: 35903845
[TBL] [Abstract][Full Text] [Related]
6. Fibroblast growth factor 23 is related to profiles indicating volume overload, poor therapy optimization and prognosis in patients with new-onset and worsening heart failure.
Ter Maaten JM; Voors AA; Damman K; van der Meer P; Anker SD; Cleland JG; Dickstein K; Filippatos G; van der Harst P; Hillege HL; Lang CC; Metra M; Navis G; Ng L; Ouwerkerk W; Ponikowski P; Samani NJ; van Veldhuisen DJ; Zannad F; Zwinderman AH; de Borst MH
Int J Cardiol; 2018 Feb; 253():84-90. PubMed ID: 29306478
[TBL] [Abstract][Full Text] [Related]
7. Biologically active adrenomedullin as a marker for residual congestion and early rehospitalization in patients hospitalized for acute heart failure: Data from STRONG-HF.
Voordes G; Davison B; Biegus J; Edwards C; Damman K; Ter Maaten J; Mebazaa A; Takagi K; Adamo M; Ambrosy AP; Arrigo M; Barros M; Celutkiene J; Čerlinskaitė-Bajorė K; Chioncel O; Cohen-Solal A; Damasceno A; Deniau B; Diaz R; Filippatos G; Gayat E; Kimmoun A; Lam CSP; Metra M; Novosadova M; Pagnesi M; Pang P; Ponikowski P; Saidu H; Sliwa K; Tomasoni D; Cotter G; Voors AA
Eur J Heart Fail; 2024 Jun; ():. PubMed ID: 38874185
[TBL] [Abstract][Full Text] [Related]
8. Adrenomedullin peptides and precursor levels in relation to haemodynamics and prognosis after heart transplantation.
Ahmed A; Kania K; Abdul Rahim H; Ahmed S; Rådegran G
ESC Heart Fail; 2023 Aug; 10(4):2427-2437. PubMed ID: 37246315
[TBL] [Abstract][Full Text] [Related]
9. Bioactive adrenomedullin a prognostic biomarker in patients with mild to moderate dyspnea at the emergency department: an observational study.
Bronton K; Wessman T; Gränsbo K; Schulte J; Hartmann O; Melander O
Intern Emerg Med; 2022 Mar; 17(2):541-550. PubMed ID: 34173962
[TBL] [Abstract][Full Text] [Related]
10. Plasma bioactive adrenomedullin as a prognostic biomarker in acute heart failure.
Self WH; Storrow AB; Hartmann O; Barrett TW; Fermann GJ; Maisel AS; Struck J; Bergmann A; Collins SP
Am J Emerg Med; 2016 Feb; 34(2):257-62. PubMed ID: 26577429
[TBL] [Abstract][Full Text] [Related]
11. Biologically Active Adrenomedullin (bio-ADM) is of Potential Value in Identifying Congestion and Selecting Patients for Neurohormonal Blockade in Acute Dyspnea.
Simonavičius J; Mikalauskas A; Čerlinskaitė K; Gayat E; Juknevičius V; Palevičiūtė E; Alitoit-Marrote I; Kablučko D; Bagdonaitė L; Balčiūnas M; Vaičiulienė D; Jonauskienė I; Motiejūnaitė J; Stašaitis K; Kukulskis A; Damalakas Š; Šimbelytė T; Taparauskaitė N; Pukanasienė G; Laucevičius A; Kavoliūnienė A; Mebazaa A; Čelutkienė J;
Am J Med; 2022 Jul; 135(7):e165-e181. PubMed ID: 35245495
[TBL] [Abstract][Full Text] [Related]
12. Bioactive adrenomedullin, proenkephalin A and clinical outcomes in an acute heart failure setting.
Molvin J; Jujic A; Navarin S; Melander O; Zoccoli G; Hartmann O; Bergmann A; Struck J; Bachus E; Di Somma S; Magnusson M
Open Heart; 2019; 6(2):e001048. PubMed ID: 31354956
[TBL] [Abstract][Full Text] [Related]
13. Albuminuria as a marker of systemic congestion in patients with heart failure.
Boorsma EM; Ter Maaten JM; Damman K; van Essen BJ; Zannad F; van Veldhuisen DJ; Samani NJ; Dickstein K; Metra M; Filippatos G; Lang CC; Ng L; Anker SD; Cleland JG; Pellicori P; Gansevoort RT; Heerspink HJL; Voors AA; Emmens JE
Eur Heart J; 2023 Feb; 44(5):368-380. PubMed ID: 36148485
[TBL] [Abstract][Full Text] [Related]
14. Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trial.
Ambrosy AP; Pang PS; Khan S; Konstam MA; Fonarow GC; Traver B; Maggioni AP; Cook T; Swedberg K; Burnett JC; Grinfeld L; Udelson JE; Zannad F; Gheorghiade M;
Eur Heart J; 2013 Mar; 34(11):835-43. PubMed ID: 23293303
[TBL] [Abstract][Full Text] [Related]
15. Circulating adrenomedullin estimates survival and reversibility of organ failure in sepsis: the prospective observational multinational Adrenomedullin and Outcome in Sepsis and Septic Shock-1 (AdrenOSS-1) study.
Mebazaa A; Geven C; Hollinger A; Wittebole X; Chousterman BG; Blet A; Gayat E; Hartmann O; Scigalla P; Struck J; Bergmann A; Antonelli M; Beishuizen A; Constantin JM; Damoisel C; Deye N; Di Somma S; Dugernier T; François B; Gaudry S; Huberlant V; Lascarrou JB; Marx G; Mercier E; Oueslati H; Pickkers P; Sonneville R; Legrand M; Laterre PF;
Crit Care; 2018 Dec; 22(1):354. PubMed ID: 30583748
[TBL] [Abstract][Full Text] [Related]
16. Circulating bioactive adrenomedullin as a marker of sepsis, septic shock and critical illness.
Lundberg OHM; Lengquist M; Spångfors M; Annborn M; Bergmann D; Schulte J; Levin H; Melander O; Frigyesi A; Friberg H
Crit Care; 2020 Nov; 24(1):636. PubMed ID: 33148300
[TBL] [Abstract][Full Text] [Related]
17. Effect of adrenergic blockade on plasma adrenomedullin concentration during static handgrip in patients with heart failure.
Krzemiński K; Nazar K; Cybulski G; Mikulski T
Clin Physiol Funct Imaging; 2006 Nov; 26(6):328-34. PubMed ID: 17042897
[TBL] [Abstract][Full Text] [Related]
18. The evaluation of the clinical utility of urocortin 1 and adrenomedullin versus proBNP in systolic heart failure.
Yıldırım E; Cengiz M; Yıldırım N; Aslan K; İpek E; Korkmaz AF; Ulusoy FR; Hatem E
Anatol J Cardiol; 2017 Mar; 17(3):184-190. PubMed ID: 25868038
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Implications of Congestion on Physical Examination Among Contemporary Patients With Heart Failure and Reduced Ejection Fraction: PARADIGM-HF.
Selvaraj S; Claggett B; Pozzi A; McMurray JJV; Jhund PS; Packer M; Desai AS; Lewis EF; Vaduganathan M; Lefkowitz MP; Rouleau JL; Shi VC; Zile MR; Swedberg K; Solomon SD
Circulation; 2019 Oct; 140(17):1369-1379. PubMed ID: 31510768
[TBL] [Abstract][Full Text] [Related]
20. Clinical Role of CA125 in Worsening Heart Failure: A BIOSTAT-CHF Study Subanalysis.
Núñez J; Bayés-Genís A; Revuelta-López E; Ter Maaten JM; Miñana G; Barallat J; Cserkóová A; Bodi V; Fernández-Cisnal A; Núñez E; Sanchis J; Lang C; Ng LL; Metra M; Voors AA
JACC Heart Fail; 2020 May; 8(5):386-397. PubMed ID: 32171764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
